Summary

Market Analysis and Insights: Global Diabetes Stem Cell Therapy Market
In 2021, the global Diabetes Stem Cell Therapy market size will be US$ million and it is expected to reach US$ million by the end of 2027, with a CAGR of % during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Stem Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Stem Cell Therapy market.

Global Diabetes Stem Cell Therapy Scope and Market Size
Diabetes Stem Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Preclinical
Clinical Phase 1,2

Segment by Application
Type 1 Diabetes
Type 2 Diabetes

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ViaCyte
Sernova
Semma Therapeutics (Vertex)
Caladrius Biosciences
Novo Nordisk
Throne Biotechnologies Inc
Athersys

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Preclinical
1.2.3 Clinical Phase 1,2
1.3 Market by Application
1.3.1 Global Diabetes Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetes Stem Cell Therapy Market Perspective (2016-2027)
2.2 Diabetes Stem Cell Therapy Growth Trends by Regions
2.2.1 Diabetes Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Stem Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Stem Cell Therapy Industry Dynamic
2.3.1 Diabetes Stem Cell Therapy Market Trends
2.3.2 Diabetes Stem Cell Therapy Market Drivers
2.3.3 Diabetes Stem Cell Therapy Market Challenges
2.3.4 Diabetes Stem Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetes Stem Cell Therapy Players by Revenue
3.1.1 Global Top Diabetes Stem Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Diabetes Stem Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Stem Cell Therapy Revenue
3.4 Global Diabetes Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Diabetes Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Stem Cell Therapy Revenue in 2020
3.5 Diabetes Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Diabetes Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Diabetes Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Stem Cell Therapy Breakdown Data by Type
4.1 Global Diabetes Stem Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Stem Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Diabetes Stem Cell Therapy Breakdown Data by Application
5.1 Global Diabetes Stem Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Stem Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetes Stem Cell Therapy Market Size (2016-2027)
6.2 North America Diabetes Stem Cell Therapy Market Size by Type
6.2.1 North America Diabetes Stem Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Diabetes Stem Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Diabetes Stem Cell Therapy Market Size by Type (2016-2027)
6.3 North America Diabetes Stem Cell Therapy Market Size by Application
6.3.1 North America Diabetes Stem Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Diabetes Stem Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Diabetes Stem Cell Therapy Market Size by Application (2016-2027)
6.4 North America Diabetes Stem Cell Therapy Market Size by Country
6.4.1 North America Diabetes Stem Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Diabetes Stem Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diabetes Stem Cell Therapy Market Size (2016-2027)
7.2 Europe Diabetes Stem Cell Therapy Market Size by Type
7.2.1 Europe Diabetes Stem Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Stem Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Stem Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Diabetes Stem Cell Therapy Market Size by Application
7.3.1 Europe Diabetes Stem Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Stem Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Stem Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Diabetes Stem Cell Therapy Market Size by Country
7.4.1 Europe Diabetes Stem Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Stem Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetes Stem Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Stem Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetes Stem Cell Therapy Market Size (2016-2027)
9.2 Latin America Diabetes Stem Cell Therapy Market Size by Type
9.2.1 Latin America Diabetes Stem Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Stem Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Stem Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Diabetes Stem Cell Therapy Market Size by Application
9.3.1 Latin America Diabetes Stem Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Stem Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Stem Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Diabetes Stem Cell Therapy Market Size by Country
9.4.1 Latin America Diabetes Stem Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Stem Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetes Stem Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Stem Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Details
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Diabetes Stem Cell Therapy Introduction
11.1.4 ViaCyte Revenue in Diabetes Stem Cell Therapy Business (2016-2021)
11.1.5 ViaCyte Recent Development
11.2 Sernova
11.2.1 Sernova Company Details
11.2.2 Sernova Business Overview
11.2.3 Sernova Diabetes Stem Cell Therapy Introduction
11.2.4 Sernova Revenue in Diabetes Stem Cell Therapy Business (2016-2021)
11.2.5 Sernova Recent Development
11.3 Semma Therapeutics (Vertex)
11.3.1 Semma Therapeutics (Vertex) Company Details
11.3.2 Semma Therapeutics (Vertex) Business Overview
11.3.3 Semma Therapeutics (Vertex) Diabetes Stem Cell Therapy Introduction
11.3.4 Semma Therapeutics (Vertex) Revenue in Diabetes Stem Cell Therapy Business (2016-2021)
11.3.5 Semma Therapeutics (Vertex) Recent Development
11.4 Caladrius Biosciences
11.4.1 Caladrius Biosciences Company Details
11.4.2 Caladrius Biosciences Business Overview
11.4.3 Caladrius Biosciences Diabetes Stem Cell Therapy Introduction
11.4.4 Caladrius Biosciences Revenue in Diabetes Stem Cell Therapy Business (2016-2021)
11.4.5 Caladrius Biosciences Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Diabetes Stem Cell Therapy Introduction
11.5.4 Novo Nordisk Revenue in Diabetes Stem Cell Therapy Business (2016-2021)
11.5.5 Novo Nordisk Recent Development
11.6 Throne Biotechnologies Inc
11.6.1 Throne Biotechnologies Inc Company Details
11.6.2 Throne Biotechnologies Inc Business Overview
11.6.3 Throne Biotechnologies Inc Diabetes Stem Cell Therapy Introduction
11.6.4 Throne Biotechnologies Inc Revenue in Diabetes Stem Cell Therapy Business (2016-2021)
11.6.5 Throne Biotechnologies Inc Recent Development
11.7 Athersys
11.7.1 Athersys Company Details
11.7.2 Athersys Business Overview
11.7.3 Athersys Diabetes Stem Cell Therapy Introduction
11.7.4 Athersys Revenue in Diabetes Stem Cell Therapy Business (2016-2021)
11.7.5 Athersys Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details